Skip to main content

Lead(s)

Lindsey Gouker, MD, MHA

IHQI Team 

Matt Huemmer, MHA, MBA

Carlton Moore, MD

Aim  

By September 30, 2026, 95% of patients seen in pre-procedures services (PPS) with a penicillin allergy label will be offered penicillin (Amoxycillin) challenge if indicated

Project Materials 

Coming Soon